The anti-in£ammatory mechanisms of minocycline, an antibiotic used in the treatment of the in£ammatory component of acne, are only partially understood. In addition to in£am-mation due to cytokines (IL-1, IL-6, TNF-a, etc.), recent studies have shown that neuropeptide-mediated neurogenic in£ammation may play an important role in cutaneous in£am-mation. The purpose of this study was to investigate minocycline-induced modulation of cutaneous production of alpha-melanocyte-stimulating hormone (a-MSH), a neuropeptide with known anti-in£ammatory activity. Two di¡erent skin models were used: explants of in£ammatory skin and reconstituted skin, both incubated with minocycline at di¡er-ent concentrations and for di¡erent time periods. Epidermal production of a-MSH, as evaluated by immuno£uorescence and immunoperoxidase techniques, showed increased expression in both models. This neuropeptide, which has an antiin£ammatory activity (notably through production of IL-10, antagonism of IL-1 and inhibition of the chemotaxis of polymorphonuclear leukocytes), thus plays a role in the anti-in£ammatory action of minocycline. Key words: in£am-mation; a-MSH; cyclines. Minocycline is an antibiotic used in the treatment of acne, particularly of its in£ammatory component. In addition to its bacteriostatic e¡ect on Propionibacterium acnes (1), minocycline acts through its own anti-in£ammatory properties by inhibiting the bacterial production of lipases and TNF-a (2, 3), the chemotaxis of polymorphonuclear leukocytes (4) and the activity of superoxide dismutase (5). However, the mechanism of minocycline action is only partially understood and could involve the modulation of other mediators, such as neuropeptides. These protein compounds released by nerve ¢bres in the skin or synthesized by some skin cells contribute to in£amma-tory events through pharmacological properties, such as modulation of mastocyte degranulation, lymphocytic activity or chemotaxis of polymorphonuclear leukocytes (6). Among the 20 or so neuropeptides present in the skin, alpha-melanocytestimulating hormone (a-MSH) seems of particular interest since it displays a clearly established anti-in£ammatory activity (7) notably by modulating interleukine production.Thus, the anti-in£ammatory activity of minocycline could be related not only to a modulation of cytokines, but also to a-MSH. Moreover, a-MSH contributes to the melanogenesis, is synthesized by keratinocytes (8) and so may possibly be related to the pigmentation induced by minocycline. Thus, the purpose of our study was to investigate minocyline modulation in vitro of cutaneous production of a-MSH.
Minocycline is an antibiotic used in the treatment of acne, particularly of its in£ammatory component. In addition to its bacteriostatic e¡ect on Propionibacterium acnes (1), minocycline acts through its own anti-in£ammatory properties by inhibiting the bacterial production of lipases and TNF-a (2, 3), the chemotaxis of polymorphonuclear leukocytes (4) and the activity of superoxide dismutase (5) . However, the mechanism of minocycline action is only partially understood and could involve the modulation of other mediators, such as neuropeptides. These protein compounds released by nerve ¢bres in the skin or synthesized by some skin cells contribute to in£amma-tory events through pharmacological properties, such as modulation of mastocyte degranulation, lymphocytic activity or chemotaxis of polymorphonuclear leukocytes (6) . Among the 20 or so neuropeptides present in the skin, alpha-melanocytestimulating hormone (a-MSH) seems of particular interest since it displays a clearly established anti-in£ammatory activity (7) notably by modulating interleukine production.Thus, the anti-in£ammatory activity of minocycline could be related not only to a modulation of cytokines, but also to a-MSH. Moreover, a-MSH contributes to the melanogenesis, is synthesized by keratinocytes (8) and so may possibly be related to the pigmentation induced by minocycline. Thus, the purpose of our study was to investigate minocyline modulation in vitro of cutaneous production of a-MSH.
Two di¡erent skin models were used: explants of in£amma-tory skin and reconstituted skin, both incubated with minocycline at di¡erent concentrations and for di¡erent time periods. The epidermal production of a-MSH was evaluated by immuno£uorescence and immunoperoxidase techniques.
MATERIALS AND METHODS

Explant technique in in£ammatory skin
Culture. Punches (4 mm in diameter) from biopsies of psoriatic skin, considered as an in£ammatory model, were incubated at 37³C in a moist atmosphere in the presence of 5% CO 2 for 3, 6, 8 or 24 h in KSFM medium (Gibro BRL, France) supplemented with penicillin 200 IU/ml-streptomycin 200 mg/ml (Boehringer-Mannheim, Germany), Fungizone 0.25 mg (Bristol-Meyers Squibb, France), epidermal growth factor 0.5 ng/ml (Gibco BRL), and bovine pituitary gland 25 mg/ml (Gibo BRL). The medium contained minocycline at the following concentrations: 1.5, 3 or 6 mg/ml. These concentrations were chosen to match that in serum, which is evaluated between 0.7 and 6.5 mg/ml (9). Medium without minocycline was used as a control. Each minocycline concentration was done in triplicate. After incubation, explants were removed from the culture medium and frozen at8 0³C. Sections (6 mm thick) were then cut with a cryostat, ¢xed in acetone at 4³C for 10 min and frozen.
Immuno£uorescence. a-MSH was detected by an immuno£uorescence ampli¢cation technique. The sections were incubated for 30 min at room temperature with a polyclonal rabbit anti-a-MSH IgG (1 : 200) (Amersham, France) and then, after washing, with a F(ab)' 2 fragment of biotinylated goat anti-rabbit antibody (1 : 50). Labelling was done using £uorescein-conjugated streptavidin (1 : 100). Counterstaining was performed with propidium iodide. Two types of negative control were provided: use of an irrelevant monoclonal antibody, CD2 of the same isotype as that of the ¢rst antibody, and omission of the ¢rst antibody. Moreover the control with pre-immune serum was negative. Slides were interpreted blindly by 2 observers using a Leitz £uorescence microscope. A mean was determined for 4 di¡erent ¢elds (640 magni¢cation) per slide. When keratinocyte staining was detected, the semi-quantitative estimation of £uores-cence intensity in the epidermis was scored as follows: 0~negative; 1~very low intensity; 2~low intensity; 3~moderate intensity; and 4~high intensity.
Reconstituted skin technique
Culture (Prunieras' technique as modi¢ed by Basset-Seguin et al. (10) ). One-centimetre squares were cut out of defatted mammaplasties and de-epidermized by heating at 56³C for 15 min. The dermis was then killed by 10 successive freezing/thawing steps for 10 min in liquid nitrogen (^180³C). Two-millimeter punches from biopsies of defatted normal skin were then placed in the centre of killed dermis. After 10 days of culture at 37³C in a moist atmosphere and in the pre-sence of CO 2 , the reconstituted skin was incubated for 3 or 6 h with 7 ml Eagle's minimum essential medium (MEM) 61 (Gibco BRL) supplemented with 10% foetal calf serum (Gibco BRL), penicillin 200 IU/ml-streptomycin 200 mg/ml (Boehringer-Mannheim), epidermal growth factor 20 ng/ml (Gibco BRL), cholera toxin 10-10 (Sigma, France) and hydrocortisone 0.4 mg/ml (Roussel, France). MEM contained minocycline at the various concentrations (Table I) , all of which were done in triplicate. Medium without minocycline was used as a control. After incubation, the reconstituted skin was removed from the culture medium and frozen at^80³C. Sections were then cut with a cryostat, ¢xed in acetone at 4³C for 10 min and frozen.
Immunoperoxidase. a-MSH was detected with an immunoperoxidase technique (DAKO kit), using phosphate-bu¡ered saline for dilution and TBS for washes. At each step, sections were incubated for 30 min at room temperature, ¢rst with a rabbit anti-a-MSH IgG (1 : 200) (Amersham), then, after washing, with a second antibody, i.e. an F(ab)' 2 fragment of biotinylated goat anti-rabbit antibody diluted in sodium azide bu¡er, and ¢nally with peroxidase-conjugated streptavidin. Revelation was performed with hydrogen peroxide and 3-amino-9-ethylcarbazole (5 s). Counterstaining was done with haemalum. Two types of negative controls were provided: use of an irrelevant monoclonal antibody of the same isotype as that of the ¢rst antibody, and omission of the ¢rst antibody. Slides were interpreted blindly by 2 observers using a Leitz white light microscope. A mean was determined for 4 di¡erent ¢elds (640 magni¢cation) per slide. Fluorescence intensity was scored semi-quantitatively: 0~negative; 1~very low intensity; 2~low intensity; 3~moderate intensity; and 4~high intensity.
Statistical analysis
Statistical opinion was sought (Dr N'Guyen) and it was concluded that no statistical test could be adequately used in this system.
RESULTS
Explants of in£ammatory skin
The results are summarized in Table II. In the presence of minocycline, an increase in epidermal staining of a-MSH over baseline values was noted for all time periods studied (3, 6, 8 and 24 h), with a maximum for a concentration of 6 mg/ml at 24 h.
Reconstituted skin
Results are summarized in Table I . In the presence of minocycline, an increase in keratinocyte staining of a-MSH over baseline values was noted for all time periods studied, from 3 mg/ml at 3 h and from 1.5 mg/ml at 6 h. Intensity was maximal for minocycline concentrations of 100 and 1,000 mg/ml at 6 h.
DISCUSSION
This in vitro study shows that a-MSH production increased in both in£ammatory and reconstituted skin beginning with the lowest minocycline concentrations tested (3 mg/ml). a-MSH is a 13 amino acid neuropeptide derived from proopionmelanocortin (POMC) (11 ) . In skin, POMC-derived peptides are detected in C ¢bres (12) as well as in various types of cells: peripheral blood mononucleate cells, immune cells and skin cells (keratinocytes, melanocytes, sebocytes, Merkel cells) (13) . Weak epidermal staining was found at basal state in in£ammatory and reconstituted skin, which is concordant with the results of previous studies showing a lack of a-MSH keratinocytic production in the absence of stimulation (14) . Epidermal staining was increased in the presence of minocycline in both in£ammatory and reconstituted skin at all incubation times studied. The skin explant model allowed us to evaluate global a-MSH production in skin, whereas the reconstituted skin model provided more speci¢c assessment of keratinocytic production. In this study, skin biopsies of psoriasis were used as in£ammatory skin model, however the results obtained on the modulation of a-MSH production by minocycline may be relevant in acne where minocycline is often used. In both models, the dose-dependent increase was maximal at the highest minocycline concentrations tested, respectively 1000 mg/ml for explant model and 6 mg/ml for reconstituted skin model. These doses are higher than the mean concentrations of minocycline noted in serum (0.7^6.5 mg/ml) (9) for explant skin model, but are similar for reconstituted skin. Increased a-MSH production in the presence of minocycline could a¡ect the di¡erent activities of the antibiotic. First, it could play a role in the anti-in£ammatory activity of minocycline, since a-MSH has both a central and peripheral anti-in£ammatory e¡ect. Its central e¡ect is apparently dependent on a modulation of the release of substance P, a neuropeptide with proin£ammatory activity (15) , and its peripheral e¡ect on inhibition of the release of certain pro-in£ammatory cytokines (IL-1, IL-6, TNF-a) (16) , production of interferon-gamma (17) and Table I . Modulation by minocycline of the expression of a-MSH by keratinocytes on reconstituted skin after 3 and 6 h of incubation with di¡erent concentrations of minocycline.
chemotaxis of polymorphonuclear leukocytes (18) . Moreover, it stimulates the production of IL-10, an anti-in£ammatory cytokine (19) . Thus, a-MSH could contribute to the antiin£ammatory e¡ects of minocycline by a mechanism of release from the nerve ¢bres containing it and subsequent synthesis by keratinocytes. In this way, it could limit the cytokine cascade, which sustains in£ammatory reaction. Moreover, the increase in a-MSH production could a¡ect the pigmentation phenomena relative to minocycline, which are rather common with this antibiotic since a-MSH stimulates melanogenesis (20) . It may be concluded from this study that minocycline induces keratinocytic production of a-MSH in in vitro models, which is an additional demonstration of the anti-in£ammatory properties of this antibiotic.
